A potential COVID-19 vaccine being developed by AstraZeneca and the University of Oxford has been put on hold after a participant in the trial developed a “potentially unexplained illness.”
The trial includes children as young as 5 years old. Earlier this year The World Health Organization’s Chief Scientist Soumya Swaminathan called the project a COVID-19 vaccine race “frontrunner”.
The participant who triggered a global shutdown of AstraZeneca’s Phase 3 Covid-19 vaccine trials is a woman in the United Kingdom who experienced neurological symptoms consistent with a rare but serious spinal inflammatory disorder called Transverse Myelitis (TM) – although this has not been officially diagnosed, the drug maker’s Chief Executive, informed investors during a private conference call set up by investment bank J.P. Morgan.
TM is a neurological disorder characterized by inflammation of the spinal cord, a major element of the central nervous system. It often results in weakness of the limbs, problems emptying the bladder and paralysis. Patients can become severely disabled and there is currently no effective cure.
Concerns over associations between TM and vaccines are well known. A review of published case studies in 2009 documented 37 cases of transverse myelitis associated with hepatitis B vaccines, measles-mumps-rubella, diphtheria-tetanus-pertussis and others. The U.S.-based Mayo Clinic concludes that the association so far is not strong enough to warrant limiting any vaccine.
The board tasked with overseeing the data and safety components of the AstraZeneca clinical trials confirmed that the participant was injected with the company’s Covid-19 vaccine and not a placebo
They stated illness can happen by chance in large trials and said it would expedite an independent review “to minimize any potential impact on the trial timeline.” They stressed such actions were routine in clinical trials. AstraZeneca stated “we are committed to the safety of our participants and the highest standards of conduct in our trials”.
AstraZeneca’s vaccine is one of three currently in late-stage clinical trials in the United States the other two being pharmaceutical giants Pfizer and Moderna. The program began in August and is working toward enrolling up to 30,000 participants across 80 sites to determine the vaccine’s safety.
The vaccine candidate, known as AZD1222, was developed using chimpanzee adenovirus and is designed to induce a protective immune response that would guard against the coronavirus. It is reported that this type of science has not been used before in an approved vaccine, but it has been tested in experimental treatments, including for the Ebola virus.
The AstraZeneca CEO reportedly stated that the vaccine candidate would most likely get protection against coronavirus for one whole year.
To date, AstraZeneca’s public statements on the pause have been sparse with details. For instance, the company has not publicly confirmed that this is the second time its trials have been stopped to investigate health events among participants.
Response and Result of Swine Flu “Pandemic”
At this point, I would like to take you back to the Swine Flu “Pandemic” of 2009.
60 million people received the Pandemrix vaccine.
GlaxoSmithKline (GSK) developed the Pandemrix vaccine, with disastrous consequences. An alleged 60 patients who suffered brain damage as a result of the vaccine were allocated £60m in compensation by the UK Government. Most of the victims were children.
Across Europe, more than 800 children are so far known to have been made ill by the vaccine. https://www.theguardian.com/science/2017/feb/09/ministers-lose-fight-to-stop-payouts-in-swine-flu-jab-narcolepsy-cases
Analysis
At this stage I would like to state that I am not medically trained – my analysis is based purely upon research undertaken, (sources attached).
Researchers have yet to produce a safe and effective vaccine against any coronavirus. When researchers were experimenting on vaccines against SARS (similar to COVID-19), trials were halted completely, after the vaccinated animals developed even more severe (and sometimes fatal) versions of SARS than the unvaccinated animals.
Screenshot from information sheet given to AstraZeneca’s vaccine trial volunteers.
- Are animal trials being undertaken in these studies?
- Are double blind placebo studies taking place? (the gold standard)
- Are pharmaceutical companies liable for any vaccine injury suffered from their product?
- Will the ingredients within the vaccines be made available to the public?
- Will the vaccine be safe and effective?
All good questions to be asked and answered before you roll up your sleeve.
But the million dollar question is would you take an experimental vaccine against a virus with a recovery rate of over 99% and one that most of us will not even suffer symptoms?
Or will it be mandatory? Watch this space…………
https://clinicaltrials.gov/ct2/show/NCT04400838
https://pubmed.ncbi.nlm.nih.gov/19880568/
https://www.statnews.com/2020/09/09/astrazeneca-covid19-vaccine-trial-hold-patient-report/
UPDATE: Trials of a Covid-19 vaccine being developed by AstraZeneca and Oxford University will resume after being paused due to a reported side-effect in a patient in the UK. Health Secretary Matt Hancock welcomed the news.
I wrote my first article for Unity News Network on 30th December 2019, and I have been writing ever since – my library is now well in excess of 200 articles.
Alternative media is essential in these times of unprecedented censorship and mainstream bias, which has ramped up exponentially during the past 2 years. The overton window of “acceptable opinion” is growing every narrower.
Having a citizen’s log, cataloguing the twists and turns of life during these turbulent times is essential.
Thank you Unity News Network for allowing me a voice on your platform.
